Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia.
about
Understanding measurements of vitality in patients with chronic kidney disease: connecting a quality-of-life scale to daily activitiesPatient-Reported Outcomes in Glomerular Disease.Course of symptoms and health-related quality of life during specialized pre-dialysis care.Decreased health-related quality of life in angiodysplasia patients: A cross-sectional cohort.Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational study.Health-related quality of life outcomes in chronic kidney disease.Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trialEpoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utility.An integrative approach to advanced kidney disease in the elderly.Implications of a reduction in the hemoglobin target in erythropoiesis-stimulating agent-treated hemodialysis patientsThe health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial.The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease.Estimated pulmonary artery systolic pressure and self-reported physical function in patients on hemodialysis.Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment.Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis.Appropriateness of anemia management in hemodialysis patients.Consequences of CKD on Functioning.Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis.Health-related quality of life in CKD Patients: correlates and evolution over time.C.E.R.A. maintains stable hemoglobin in Latin American patients on dialysis.Health-related quality of life in hemodialysis patients: an Iranian multi-center study.Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney diseaseA prospective observational study of early intervention with erythropoietin therapy and renal survival in non-dialysis chronic kidney disease patients with anemia: JET-STREAM Study.The psychosocial correlates of quality of life in the dialysis population: a systematic review and meta-regression analysis.Health-related quality of life in different stages of renal failure.Biosimilar recombinant human erythropoietins ("epoetins") and future erythropoiesis-stimulating treatments.Assessing and improving the health-related quality of life of patients with ESRD.Treating pain to improve quality of life in end-stage renal disease.How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The "forgotten adjunct therapy": the link between ESA use and control of hyperparathyroidism in chronic kidney disease.Emerging drugs for treatment of anemia of chronic kidney disease.A Trial of Extending Hemodialysis Hours and Quality of Life.How Can We Improve the Quality of Life of Dialysis Patients?A Comparative Study of the Hemoglobin-Maintaining Effects Between Epoetin-β Pegol and Darbepoetin-α in Patients with Chronic Kidney Disease During 3 Months Before Dialysis Initiation.Prognostic Value of the Delivery Dialysis Dose on Twice-Weekly Hemodialysis Patients.Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management.Individualizing anaemia therapyExercise in Patients on Dialysis: A Multicenter, Randomized Clinical Trial.Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anaemic chronic kidney disease patients.Association between changes in quality of life and mortality in hemodialysis patients: results from the DOPPS.Dosing regimen and tolerability of methoxy polyethylene glycol-epoetin beta in Chinese dialysis patients.
P2860
Q28727189-5BC3BD0B-F4FD-4FD6-9180-15963DC59D9CQ30249861-A908343D-B2FD-4AE9-927B-B5FBF273E807Q31156852-04023592-494E-4C68-8741-E05F311F7334Q33731905-ADD561C5-BE85-4FB9-9F7D-8D4C16EDAF0AQ33827406-753235C1-996E-4893-91AE-19EAC260A361Q33976245-C50F82DA-1946-4729-A42B-7D4F57141E8CQ34340711-79CF2B1A-A227-48BA-9E1F-21F14BB2D814Q35162053-DAFB373A-E278-4C5C-BF97-BD3516ADAF62Q35738794-1A8F4B30-DCF6-495E-BB9C-58FBA4917677Q35791745-DC5E4D1D-E03F-423A-80FA-71A5A1757628Q36072666-27DA97ED-7409-42AC-92B8-4F4D28BCA0BBQ36073903-08690858-8D93-42A3-9B8C-298A964C7F55Q36355323-C15C21AB-B1A0-402A-A514-DB6EFE96E4BAQ36437245-86FB57CD-77B2-4691-B9AC-7F65DED3A8D8Q36476556-77F52800-14D0-4C71-81B6-75419597D24FQ37099330-C1A705B2-D1EC-49E5-A500-60F23905FB76Q37141165-CCDCCEC0-02B1-48CC-94F4-288DB2C0F29AQ37195095-64D9E7C7-5E4D-40D8-B857-0F4C465573EDQ37297641-AF5B140E-F71C-45C1-9AA8-B85AA61DF344Q37298741-095C1174-F2FB-47FE-8353-7AA090D5F49EQ37347847-2B555118-1F3D-459B-B2F8-E811AED46735Q37438625-18DB3F78-FB8F-40E0-A43F-95955F76B24AQ37452708-FEC0BEE5-2F0C-4C18-823C-1AFC11ECBFFFQ37909197-936E6D75-BAEE-49C3-8EBC-82ADF5CFD0EBQ37994729-78B83A36-31EB-4F8F-BED6-222695F3BF14Q37999380-719135E0-40EA-481F-82D7-8784978CF5F0Q38054516-BB4E7583-20C8-4297-8765-1DAAE0F7F045Q38083767-8698629A-8249-40E4-9640-9EAD224430A0Q38111803-D055687B-8DE9-4245-A423-E6D485AFC26FQ38137205-6B4FE021-D4F7-48AF-B572-7DDFBC42B8BBQ38381381-DD421DFB-47E6-4C0E-8135-627D964F71A3Q38693389-AD5F29B9-B988-4317-B39C-04BAB95E41DBQ38762167-8ED56F61-47A8-48B9-8AC5-E1403297AEC2Q38973939-37B67832-ED15-44FE-9602-008FA82C6688Q39371536-3CD2FDD4-7CD8-430B-9558-8A4FFA4A18D5Q40329273-F292A54C-3A2B-4BFF-A41C-6977088512B5Q40445746-123ADEDB-2559-4304-8AB2-12094217EEEFQ40564625-826A0071-BA48-4E50-9BE7-356FB35E23E5Q40715073-A80D579D-0C60-4B52-96B8-F365EB861843Q43525009-64ABD14A-BED5-49C2-9EEA-56DED7BF8ED3
P2860
Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Interpretation and review of h ...... eceiving treatment for anemia.
@ast
Interpretation and review of h ...... eceiving treatment for anemia.
@en
type
label
Interpretation and review of h ...... eceiving treatment for anemia.
@ast
Interpretation and review of h ...... eceiving treatment for anemia.
@en
prefLabel
Interpretation and review of h ...... eceiving treatment for anemia.
@ast
Interpretation and review of h ...... eceiving treatment for anemia.
@en
P356
P1433
P1476
Interpretation and review of h ...... eceiving treatment for anemia.
@en
P2888
P356
10.1038/KI.2008.414
P407
P577
2008-08-27T00:00:00Z
P5875
P6179
1009269040